A larger phase II trial of RT001 for the treatment of hyperhidrosis
Latest Information Update: 12 Jan 2016
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Hyperhidrosis
- Focus Therapeutic Use
- 12 Jan 2016 New trial record
- 07 Jan 2016 This trial is expected to begin in the second half of 2016, according to a Revance Therapeutics media release.